U.S. Capital Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
16,262
+778
| +5% | +$54.4K | 0.03% | 404 |
|
|
2025
Q1 | $1.14M | Buy |
15,484
+10,551
| +214% | +$775K | 0.03% | 400 |
|
|
2024
Q4 | $323K | Buy |
4,933
+1,008
| +26% | +$66K | 0.01% | 665 |
|
|
2024
Q3 | $306K | Sell |
3,925
-907
| -19% | -$70.7K | 0.01% | 582 |
|
|
2024
Q2 | $377K | Buy |
4,832
+219
| +5% | +$17.1K | 0.01% | 515 |
|
|
2024
Q1 | $313K | Sell |
4,613
-925
| -17% | -$62.7K | 0.01% | 559 |
|
|
2023
Q4 | $373K | Buy |
5,538
+1,809
| +49% | +$122K | 0.01% | 508 |
|
|
2023
Q3 | $253K | Sell |
3,729
-875
| -19% | -$59.3K | 0.01% | 553 |
|
|
2023
Q2 | $330K | Buy |
4,604
+87
| +2% | +$6.23K | 0.02% | 514 |
|
|
2023
Q1 | $314K | Buy |
4,517
+2,814
| +165% | +$195K | 0.01% | 525 |
|
|
2022
Q4 | $115K | Buy |
+1,703
| New | +$115K | 0.01% | 714 |
|